Chronic Kidney Disease

The AJMC® Chronic Kidney Disease compendium is a comprehensive resource for clinical news and expert insights on the condition and treatment of loss of kidney function.

Latest News

The investigators concluded that epidemiological inequity in CKD and cardiovascular disease remains an important issue that requires further study of potential interventions. | Image credit: filins - stock.adobe.com
Disparities in CKD-Associated Cardiac Arrest Across Demographics

March 22nd 2025

Non-Hispanic Black populations face the highest risk of death from chronic kidney disease (CKD)–associated cardiac arrest, a study found.

Naz Urooj | Image credit: Interwell Health
Contributor: Data, Education, and Community: The Winning Formula for Addressing SDOH for Kidney Care Patients

March 21st 2025

Image Credit: selote - stock.adobe.com
New Guideline Updates to Slow CKD Progression and Reduce Cardiovascular Risk

March 10th 2025

Doctor holding card that says furosemide | Image credit: MQ-Illustrations – stock.adobe.com
FDA Expands Furosemide Injection Label to Treat Edema in CKD

March 7th 2025

Yo-Yo Dieting | Image Credit: © Karen Roach-stock.adobe.com
Weight Fluctuation Threatens Kidney Health in Type 1 Diabetes

February 4th 2025

Population Health Management of Chronic Kidney Disease (CKD)

An expert panel discusses chronic kidney disease (CKD), its impact on cardiovascular disease, and the methods of treatment used on the patient populations.

Panel members

More News

Image of kidneys
November 21st 2022

New Clinical Guidelines Recommend Finerenone for CKD Associated With T2D

Rose McNulty
Updated Kidney Disease: Improving Global Outcomes guidelines and a consensus report with the American Diabetes Association support the use of finerenone in certain patients who have chronic kidney disease (CKD) that may be linked to type 2 diabetes (T2D).
What We're Reading
November 17th 2022

What We’re Reading: Tenapanor Recommended for Dialysis; Home Births Up During Pandemic; Call for RSV, Flu Emergency

AJMC Staff
FDA advisers voted in favor of approving Ardelyx’s tenapanor for patients with chronic kidney disease on dialysis; US home births increased by about 12% between 2020 and 2021; surges in respiratory viruses, especially respiratory syncytial virus (RSV) among younger children are putting pediatric hospitals at capacity.
Kidney
November 3rd 2022

Glomerular Filtration Rate Based on Cystatin C More Accurate for Predicting CVD, Mortality

Julia Bonavitacola
A prospective population-based cohort study found that glomerular filtration rate based on cystatin C was more sensitive and specific for cardiovascular disease (CVD) and mortality risks compared with glomerular filtration rate based on creatinine.
Removal of Race Adjustment Improved Bias, Accuracy in eGFR Equations for Black Adults
October 31st 2022

Removal of Race Adjustment Improved Bias, Accuracy in eGFR Equations for Black Adults

Julia Bonavitacola
A systematic review found that alternative approaches to calculating estimated glomerular filtration rate (eGFR) were worth looking into to properly account for diversity in populations.
Julianne Malveaux, PhD
October 23rd 2022

Contributor: Congress Must Fix Patient Protection Statute Upended by Supreme Court

Julianne Malveaux, PhD
The author, the dean of the College of Ethnic Studies at California State University Los Angeles, says a Supreme Court ruling could upend insurance protections for patients with kidney diseases, disproportionately hurting those who are Black, Hispanic, Asian, and other diverse ethnicities.
Someone taking a survey
October 17th 2022

NKF Touts Potential of Kidney Disease Patient Registry to Yield Real-World Data

Julia Bonavitacola
The launch of the National Kidney Foundation’s first nationwide registry of patients with kidney disease could help link patient data with laboratory and clinical information.
Kidneys
October 13th 2022

Anemia in CKD Associated With Lower eGFR, Adverse Outcomes

Julia Bonavitacola
A cross-sectional study found that severe anemia was common in patients with chronic kidney disease (CKD) and was associated with lower glomerular filtration rate (eGFR) and multiple adverse outcomes.
Kidneys
October 11th 2022

Heat Exposure Associated With Emergency Visits for Patients With Kidney Disease

Julia Bonavitacola
An increased risk of emergency department visits for patients with kidney disease was found when patients were exposed to extreme heat.
Kidneys
October 7th 2022

New eGFR Formula May Inappropriately Label Black Potential Kidney Donors as Having CKD

Julia Bonavitacola
This study found that the recent change to remove race from the calculation of estimated glomerular filtration rate (eGFR) may incorrectly label potential donors who are Black as having chronic kidney disease (CKD).
Doctor's desk
October 4th 2022

Decline in Health Care Services for Patients With CKD Linked to COVID-19 Pandemic

Julia Bonavitacola
A retrospective observational study found that there was a decline in health care services for patients with chronic kidney disease (CKD) during the early months of the COVID-19 pandemic.
Two people working at a computer
September 26th 2022

Kidney Transplant Recipients Able to Find Stable Work Post Surgery

Julia Bonavitacola
A recent report found that 56% of patients from The Netherlands who underwent a kidney transplant were able to work and functioned well while working.
Kidneys
September 24th 2022

Genomic Testing Could Be More Beneficial for Patients With CKD

Julia Bonavitacola
Genomic testing can benefit patients with chronic kidney disease (CKD) as more causative genes are identified and evidence for clinical utility is discovered.
The Role of MRAs in CKD and CV Treatment
September 21st 2022

The Role of MRAs in CKD and CV Treatment

Dr Agarwal provides a deep dive into the use of nonsteroidal mineralocorticoid receptor antagonists in CKD therapy.
Treating CKD Using Multiple Methods
September 21st 2022

Treating CKD Using Multiple Methods

Dr Feldman concludes the treatment landscape overview by discussing glycemic control, SGLT2 inhibitors, and other important management techniques.
Kidneys and heart
September 19th 2022

Use of Anticoagulants Has Increased for Patients With Atrial Fibrillation, CKD

Julia Bonavitacola
A recent study found that patients with chronic kidney disease and atrial fibrillation are increasingly using direct oral anticoagulants.
Air pollution
September 13th 2022

Improved Air Pollution Levels Linked With Less Renal Function Decline During COVID-19 Pandemic

Julia Bonavitacola
A retrospective cohort study found that a drop in events signaling renal function decline during the COVID-19 pandemic could be associated with a decrease in fine particulate matter concentration.
Milken Institute's Sarah Wells Kocsis Talks About CKD Care Moving Forward
September 8th 2022

Milken Institute's Sarah Wells Kocsis Talks About CKD Care Moving Forward

Julia Bonavitacola
Sarah Wells Kocsis, MBA, coauthor of the Milken Institute report, “Chronic Kidney Disease: Finding a Path to Prevention, Earlier Detection, and Management,” discusses how the health care system can better suit the needs of patients with chronic kidney disease (CKD).
Weight scale
September 6th 2022

Low Handgrip Strength, Obesity Associated With Increased Risk of CKD in Women

Julia Bonavitacola
Post-menopausal women who had dynapenic-abdominal obesity, determined by hand-grip strength and waist circumference, had a higher risk of chronic kidney disease (CKD) compared with controls.
Sarah Wells Kocsis
August 30th 2022

Milken Institute's Sarah Wells Kocsis Outlines How to Improve Earlier Detection of CKD

Julia Bonavitacola
Sarah Wells Kocsis, MBA, is co-author of the Milken Institute report, “Chronic Kidney Disease: Finding a Path to Prevention, Earlier Detection, and Management.” She spoke to The American Journal of Managed Care® about the findings of the report and how they can be incorporated into care for patients with chronic kidney disease (CKD).
Milken Institute's Sarah Wells Kocsis on How Climate Change, Aging Impact CKD Care
August 24th 2022

Milken Institute's Sarah Wells Kocsis on How Climate Change, Aging Impact CKD Care

Julia Bonavitacola
Sarah Wells Kocsis, MBA, is co-author of the Milken Institute report, “Chronic Kidney Disease: Finding a Path to Prevention, Earlier Detection, and Management.” She spoke to The American Journal of Managed Care® about the findings of the report and how they can be incorporated into care for patients with chronic kidney disease (CKD).
SGLT2 Inhibitors, Combination Therapy Needed to Stem the Tide of CKD in Diabetes
August 20th 2022

SGLT2 Inhibitors, Combination Therapy Needed to Stem the Tide of CKD in Diabetes

Mary Caffrey
Katherine R. Tuttle, MD, FASN, FACP, FNKF, a nephrologist from the University of Washington and Providence Health Care, discussed new consensus guidelines that call for the early use of sodium glucose cotransporter 2 (SGLT2) inhibitors, GLP-1 receptor agonists, and finerenone in the care of patients with both chronic kidney disease (CKD) and diabetes.
Sarah Wells Koscis, MBA, Milken Institute
August 14th 2022

Milken Institute's Sarah Wells Kocsis Highlights Key Findings of Her Research on CKD

Julia Bonavitacola
Sarah Wells Kocsis, MBA, is co-author of the Milken Institute report, “Chronic Kidney Disease: Finding a Path to Prevention, Earlier Detection, and Management.” She spoke to The American Journal of Managed Care® about the findings of the report and how they can be incorporated into care for patients with chronic kidney disease (CKD).
Money wrapped by a stethoscope
August 11th 2022

Largest Medicare Advantage Plans Pay Large Markups for Dialysis, Could Increase Out-of-Pocket Spending

Julia Bonavitacola
A recent study found that the largest Medicare Advantage plans pay large markups to large dialysis organizations, and these inflated payments could increase out-of-pocket expenses for patients.
As Health Disparities “Weave Their Way Through Hypertension,” New Agents Are on the Way
August 8th 2022

As Health Disparities “Weave Their Way Through Hypertension,” New Agents Are on the Way

Mary Caffrey
Coverage from the 2022 Congress of the American Society for Preventive Cardiology (ASPC) in Louisville, Kentucky, featuring 3 experts on aspects of hypertension treatment: Keith C. Ferdinand, MD, of Tulane University School of Medicine; Kim Allan Williams, MD, of the University of Louisville; and George C. Bakris, MD, of the University of Chicago Medicine.
Patient receiving care over Facetime
August 4th 2022

Remote Management of Renal Function May Reduce Mortality, HF Hospitalizations

Julia Bonavitacola
A new trial has found that patient management through remote means could reduce all-cause mortality and hospitalizations for heart failure (HF) in patients with renal impairment.
Surgeon holding kidney
August 1st 2022

Model Suggests Giving Kidneys to Patients on Dialysis a Better Use of Resources

Julia Bonavitacola
A recent modeling study found that allocating kidneys to patients receiving dialysis was a better use of the organs from a societal perspective compared with giving kidneys to those on a preemptive waiting list.
Older person's hands
July 30th 2022

Frailty Associated With Risk of ESKD, Mortality in Patients With CKD

Julia Bonavitacola
A retrospective cohort study found that frailty was prevalent in patients with chronic kidney disease (CKD) and that the adverse effects could include end stage kidney disease (ESKD) and mortality.
Kidneys
July 27th 2022

Lipid Dysregulation Predictive of CKD Risk, Onset

Julia Bonavitacola
A recent study found that lipid dysregulation was predictive of the risk of chronic kidney disease (CKD) and occurred years before the onset of CKD.
Factory pollution
July 21st 2022

Long-term Exposure to Air Pollution Associated With CKD

Julia Bonavitacola
A population-based cohort study found that carbon monoxide and sulfur dioxide exposure was associated with chronic kidney disease (CKD).
Kidneys and heart
July 18th 2022

Difference in eGFR Values Based on Cystatin C vs Creatinine Could Indicate Higher HF Risk

Julia Bonavitacola
A prospective cohort study found that in patients with chronic kidney disease, large differences in their glomerular filtration rate (eGFR) based on cystatin C vs creatinine were associated with risk of incident heart failure (HF).
<12345678
...
12>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo